Oracle acquires Phase Forward
Oracle recently announced that it has agreed to acquire Phase Forward, a provider of e-clinical and drug safety solutions.
Oracle Corp., the world's second- largest software maker, agreed to buy Phase Forward Inc. for about $685 million to add clinical-trial software and services that help drug companies develop products and ensure safety.